scorecardresearch
Follow Us:
Wednesday, July 06, 2022

Nine of 194 countries keeping pledge to eradicate hepatitis: WHO summit

There are 325 million confirmed hepatitis cases worldwide -- but the estimated diagnosis rates for hepatitis B and C, two of five types, are just 10 and 20 per cent respectively.

By: AFP | Sao Paulo |
November 2, 2017 7:20:30 am
hepatitis, hepatitis b, hepatitis c, who summit brazil 2017, world health organisation, sao paulo, world news, health news, indian express Host Brazil promoted its successful widespread testing strategy, which has seen 28 million screenings carried out in the last six years, aiming to reach 200 million by 2030 to cover almost its entire population. (Representational image)

Only nine of 194 countries which pledged last year to eradicate hepatitis by 2030 are working towards that goal, according to figures revealed at the second World Hepatitis Summit in Brazil. Egypt, Georgia, Germany, Iceland, Japan, The Netherlands, Australia, Qatar and Brazil are the only countries taking steps to overcome the disease, a liver inflammation which kills 1.3 million people every year.

The three-day summit in Sao Paulo — organised by the World Health Organisation (WHO) and the World Hepatitis Alliance — welcomed representatives from 80 governments and around 200 experts to discuss diagnosis and treatment.

Host Brazil promoted its successful widespread testing strategy, which has seen 28 million screenings carried out in the last six years, aiming to reach 200 million by 2030 to cover almost its entire population. “These results bring hope that the elimination of hepatitis can and will become a reality,” said Gottfried Hirnschall, director of WHO’s Department of HIV and Global Hepatitis Program.

Access to treatment was also discussed, after the WHO said on Tuesday a record three million people received hepatitis C treatment in the last two years, and 2.8 million received type B treatment in 2016. But millions are still denied breakthrough treatments such as sofosbuvir and daclatasvir — which have a 95 per cent success rate and work in 12 weeks.

Best of Express Premium
Funding winter sets in for Indian startups, staff out in the cold: Over 1...Premium
New worry in J&K: Officers say militancy entering a ‘secretive, dange...Premium
Cell therapy cancer centre takes shape in Bengaluru, trials are onPremium
Explained: Why monsoon is expected to pick up in JulyPremium

For humanitarian organisation Medecins Sans Frontieres (Doctors Without Borders), the solution is comparable generics. “Governments must use every tool in their toolbox to fight for access to lower-priced generics,” said Jessica Burry, pharmacist for MSF’s Access Campaign, suggesting governments should “issue compulsory licenses” when patents block access.

There are 325 million confirmed hepatitis cases worldwide — but the estimated diagnosis rates for hepatitis B and C, two of five types, are just 10 and 20 per cent respectively.

Express Explained Go beyond the news. Understand the headlines with our Explained stories

📣 Join our Telegram channel (The Indian Express) for the latest news and updates

For all the latest World News, download Indian Express App.

  • Newsguard
  • The Indian Express website has been rated GREEN for its credibility and trustworthiness by Newsguard, a global service that rates news sources for their journalistic standards.
  • Newsguard
0 Comment(s) *
* The moderation of comments is automated and not cleared manually by indianexpress.com.
Advertisement
Advertisement
Advertisement
Advertisement